Elizabeth L. Hougen

EVP, Finance and Chief Financial OfficeratIonis Pharmaceuticals· In proxies 2021–2025

Pay in FY2025Ionis Pharmaceuticals stock +126.3% the same year

Elizabeth L. Hougen was paid $4.4M in FY2025 (Dec). Ionis Pharmaceuticals stock rose 126.3% that year.

Pay$100 in the stock at the end of FY20 → $202

Pay is from the Summary Compensation Table of each Ionis Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

IONS
Ionis PharmaceuticalsPublic company · 5 yr
- EVP, Finance and Chief Financial Officer2021 – Present · 5 yrStock in role -25%

Roles come from the proxy statements of each company.

Activity

Pay
Ionis Pharmaceuticals CFO pay rose 18% to $2.9M. The stock rose 34% in FY2023 (Dec).
DEF 14AApr 25, 2024
Pay
Ionis Pharmaceuticals CFO pay fell 40% to $2.5M. The stock rose 24% in FY2022 (Dec).
DEF 14AApr 25, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?